DaVita Labs, a chronic kidney disease specialty laboratory, today announced the appointment of Leslie Mirani as DaVita Labs’ new vice president and general manager.

Mirani brings to DaVita Labs™ more than 25 years experience in commercial sales and marketing – primarily renal-focused – in the pharmaceutical industry. Mirani’s previous roles included working for Human Genome Sciences as an immunology sales director and as vice president for Amgen’s nephrology business unit for 18 years. She graduated from Ohio State and is a registered clinical dietician.

“Leslie’s extensive background will give us the momentum to move forward with our future goals and continue to provide great service, quality, technology and education to keep us at the front end of new developments within the industry,” said DaVita Labs President Chris Rucker.

DaVita Labs has 86,700 square feet dedicated to its state-of-the-art clinical diagnostic laboratories between its two locations in Fort Lauderdale and DeLand, Fla. The laboratories feature the latest in renal-specific methodology and technology for delivering quality test results. The DaVita Labs clinical laboratory team is led by experienced scientists and pathologists, and receives formal guidance from top nephrologists in the industry.

DaVita and DaVita Labs are trademarks or registered trademarks of DaVita Inc. All other trademarks are the property of their respective owners.

About DaVita Labs

DaVita Labs, a division operating within DaVita Inc., provides quality, on-time, accurate results to help effectively identify and manage kidney patients across the nation. As a cutting-edge chronic kidney disease (CKD) specialty laboratory, DaVita Labs features the latest in end stage renal disease-specific methodology and technology for delivering quality dialysis test results. DaVita Labs is fully accredited by the federal and state governmental agencies, and the College of American Pathologists. For more information, please visit www.davitalabs.com or call 877-200-3181.

About DaVita

DaVita Inc., a Fortune 500® company, is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. DaVita strives to improve patients’ quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. As of Sept. 30, 2011, DaVita operated or provided administrative services at 1,777 dialysis facilities, serving approximately 138,000 patients. DaVita supports numerous programs dedicated to creating positive, sustainable change in communities around the world. The company’s leadership development initiatives and social responsibility efforts have been recognized by Fortune, Modern Healthcare, Newsweek and WorldBlu. For more information, please visit www.davita.com.